U.S. Thyroid Ablation Devices Market Size & Outlook
U.S. thyroid ablation devices market, 2018-2030 (US$M)
Related Markets
U.S. thyroid ablation devices market highlights
- The U.S. thyroid ablation devices market generated a revenue of USD 41.4 million in 2023 and is expected to reach USD 74.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
- In terms of segment, radiofrequency ablation was the largest revenue generating type in 2023.
- Microwave Ablation is the most lucrative type segment registering the fastest growth during the forecast period.
Thyroid ablation devices market data book summary
| Market revenue in 2023 | USD 41.4 million |
| Market revenue in 2030 | USD 74.3 million |
| Growth rate | 8.7% (CAGR from 2023 to 2030) |
| Largest segment | Radiofrequency ablation |
| Fastest growing segment | Microwave Ablation |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiofrequency Ablation, Microwave Ablation |
| Key market players worldwide | Boston Scientific Corp, BVM Medical, Integra Lifesciences Holdings Corp, Johnson & Johnson, Medtronic PLC, Olympus Corp, Terumo Corp, Theraclion, Medwave, StarMed |
Other key industry trends
- In terms of revenue, U.S. accounted for 24.6% of the global thyroid ablation devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. thyroid ablation devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 35.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Thyroid Ablation Devices Market Scope
Thyroid Ablation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. thyroid ablation devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid ablation devices market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 49.28% in 2023. Horizon Databook has segmented the U.S. thyroid ablation devices market based on radiofrequency ablation, microwave ablation covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held a lucrative share of the thyroid ablation devices market in 2022. The country has a welldeveloped healthcare system with advanced treatment facilities. Surgeons in the U.S. are increasingly utilizing Radiofrequency Ablation (RFA) devices for thyroid nodule treatment.
Before the introduction of RFA, the standard treatment for both, malignant and benign thyroid nodules, was thyroidectomy, which created the need for postsurgical thyroid hormone supplementation. However, for some patients with thyroid nodules, RFA may be a preferred option as it maintains thyroid function.
RFA has been widely used to treat varicose veins, liver tumors, and other diseases. RFA received FDA approval in 2018, and several medical centers, such as UT Southwestern, have started using this approach to treat benign thyroid nodules.
Reasons to subscribe to U.S. thyroid ablation devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. thyroid ablation devices market databook
-
Our clientele includes a mix of thyroid ablation devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. thyroid ablation devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. thyroid ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. thyroid ablation devices market size, by type, 2018-2030 (US$M)
U.S. Thyroid Ablation Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
